top of page

Our Research

Cancerous cells accumulate numerous harmful genetic aberrations, yet they can override normal cellular checkpoints and continuously proliferate. They seem to do so, in part, by taking advantage of cellular recovery pathways. We aim to identify new pathways that cancers rely on for survival, with the ultimate goal of providing new anti-cancer therapeutic logistics.

DNA 그림.jpg
DNA 그림.jpg

Research Summary

Maintenance of genomic integrity is essential for all life forms. Loss of genomic integrity can lead to various abnormalities, including cell death, aging, and cancers. Understanding the molecular processes that preserve genomic integrity is important in biological and clinical sciences.

RESEARCH SUMMARY

Cancers develop therapy resistance via multiple mechanisms. Some of these refractory cancers may rely on heightened activities of genome-stabilizing pathways. We use synthetic lethality approaches to identify new genetic dependencies of cancers. 

홈피 그림.jpg
홈피 그림.jpg

RESEARCH SUMMARY

We employ a range of experimental tools to decipher functional and structural features of genome-stabilizing factors. These information may provide new avenues for anti-cancer strategies.

Research Tools

We use a variety of modern technologies to tackle our research hyothesis

Our Collaborators

George-Lucian Moldovan Lab
@ PennState Univ., USA

With the Moldovan Lab, we design genome-wide CRISPR knockout screens to identify new synthetic lethality factors in various cancer genetic backgrounds
 

Tony Huang Lab
@ NYU, USA

With the Huang Lab, we study the role of DNA repair and Fanconi Anemia proteins in replication fork stress response
 

Chosun Univ. MRC Labs
@ Gwangju, Korea

 

With the several MRC labs, we explore roles of DNA homologous recombination repair factors and genomic instability. We also study role of RNA metabolizing factors and stress granules
 

Center of Genomic Integrity, IBS/UNIST
Korea

 

With the IBS/CGI and UNIST labs, we study the role of DNA replication factors and chemotherapeutic drugs in genomic stability and cellular survival
 

DGIST Labs
@ Daegu, Korea

With Jinhae Kim Lab, we use NMR to study role of disordered structures in protein-protein interactions 

With Youngtae Jeong Lab, we study role of DNA repair proteins cancer drug resistance in cancer organoid models

With Minsik Kim Lab, we interrogate proteomic changes under genotoxic stresses

With Jong-Chan Lee Lab, we interrogate phase separations of DNA repair and replication fork-associated proteins  
 

Gaelle Legube Lab
@ Univ. of Toulouse, France

With the Legube lab, we use genome-wide Chromatin Immunoprecipitation-sequencing to identify protein enrichment regions in chromatin
 

Youngju Lee Lab
@ Pusan Univ., Korea

With the Lee lab, we utilize PROTAC and RIBOTAC technologies to selectively target and inactivate DNA damage response or cancer-promoting factors in cancer cells 
 

Jihye Paik Lab
@ Cornell Univ. Weil Medical School

With the Paik lab, we interrogate mechanisms that support telomere integrity in glioma and other types of cancers.
 

bottom of page